Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Inclusion Criteria
- Women without reproductive system infection complications.
- Three regular menstrual cycles before the study(21-35 days per cycle with 3-7 day's bleeding period, without amenorrhea or irregular bleeding).
- Healthy women,aged 20-35 years who wish to use a contraceptive.
- ...
- Women without reproductive system infection complications.
- Three regular menstrual cycles before the study(21-35 days per cycle with 3-7 day's bleeding period, without amenorrhea or irregular bleeding).
- Healthy women,aged 20-35 years who wish to use a contraceptive.
- Willingness to not use other forms of hormonal treatment.
- Signed informed consent prior to entry into the trial.
Exclusion Criteria
- Any contraindication to the use of oral contraceptives.
- Vascular, metabolic, hepatic, renal, oncologic and other diseases.
- Any contraindication to the use of oral contraceptives.
- Vascular, metabolic, hepatic, renal, oncologic and other diseases.
Summary
- Conditions
- Oral Contraceptive
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 35 years
- Gender
- Only females
Inclusion Criteria
- Women without reproductive system infection complications.
- Three regular menstrual cycles before the study(21-35 days per cycle with 3-7 day's bleeding period, without amenorrhea or irregular bleeding).
- Healthy women,aged 20-35 years who wish to use a contraceptive.
- ...
- Women without reproductive system infection complications.
- Three regular menstrual cycles before the study(21-35 days per cycle with 3-7 day's bleeding period, without amenorrhea or irregular bleeding).
- Healthy women,aged 20-35 years who wish to use a contraceptive.
- Willingness to not use other forms of hormonal treatment.
- Signed informed consent prior to entry into the trial.
Exclusion Criteria
- Any contraindication to the use of oral contraceptives.
- Vascular, metabolic, hepatic, renal, oncologic and other diseases.
- Any contraindication to the use of oral contraceptives.
- Vascular, metabolic, hepatic, renal, oncologic and other diseases.
Tracking Information
- NCT #
- NCT02021097
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Chengliang Xiong, Dr Family Planning Research Institute of TJMC,HUST
- Chengliang Xiong, Dr Family Planning Research Institute of TJMC,HUST
Get Well Soon